Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @bio1x1
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @bio1x1
-
Make sure to catch fireside chats from Barbara Dalton of
@pfizer and other key biotech and pharma leaders, including@EvanLohMD,@ParatekPharma; Ted W. Love,@GBT_news; Michael M. Morrissey,@ExelixisInc and Carol Lynch,@Sandoz_Global at#BIOCEO20! View the complete program
pic.twitter.com/pVgxsC6mTB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BIO 1x1 Partnering proslijedio/la je Tweet
Publishing 5th report on highly prevalent chronic disease tomorrow - hypertension & heart failure:
http://www.bio.org/ia-reports
Cardio overall:
--Clinical success rates
--VC funding
--Pipeline growth by disease
HT and HF:
--Trial starts
--Pipeline NCEs by phase
--FDA approved MOAsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Download your copy of BIO’s first annual report on diversity and inclusion in biotechnology at http://RightMixMatters.org
#rightmixmatterspic.twitter.com/RnPLGDjfuG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What's next in fighting solid tumors? Dr. Benjamin Cowen, CEO of
@ImmunoMet, a clinical stage biotech company developing anti-tumor and immune-metabolism therapies, will speak about that and his impressive experience in biotech at#BIOCEO20.https://www.bio.org/blogs/meet-immunomets-dr-benjamin-cowen-speaker-bioceo20 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BIO will be releasing a new Industry Analysis report tomorrow on hypertension and heart failure. Request your copy now and receive it via email when it becomes available: https://bio.org/ia-reports pic.twitter.com/aJcwHSvQ0l
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
See who you can meet at
#BIOCEO20, the must-attend meeting for top investment firms in the region! More than 340 investors have already registered, including@CanaccorGenuity,@jpmorgan and@pappas_capital.pic.twitter.com/psXb2DtcIq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BIO 1x1 Partnering proslijedio/la je Tweet
Looking forward to this panel at BIO
@IAmBiotech in a few weeks. Come along to hear more about communicating evidence of a therapy's value.https://twitter.com/synlogic_tx/status/1221899448684568576 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you
@NYCEDC for providing scholarships to NYC’s innovative biotechs to attend#BIOCEO20 and pitch investors. See you next week! http://bit.ly/2vL49Bo pic.twitter.com/TGQVHJeOK3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PANEL SPOTLIGHT
Catch the Market Performance and IPO Class of 2020 panel at #BIOCEO20 and examine whether the overall market will experience a cooling off period in 2020 or if we are at the beginning of a long-term growth cycle. View the complete program
pic.twitter.com/xMTSMDwYuv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Download your copy of BIO’s first annual report on diversity and inclusion in biotechnology at http://RightMixMatters.org
#rightmixmatterspic.twitter.com/BDiOOmmp56
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BIO 1x1 Partnering proslijedio/la je Tweet
Meet Shawn Tomasello – Speaker at
#BIOCEO20:https://buff.ly/2NYXytpHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Syneos One team at Syneos Health is dedicated to delivering fully integrated solutions focused on cost, speed, and risk mitigation to increase an asset’s NPV. Schedule a meeting with us at
#BIOCEO20 to learn more.pic.twitter.com/d4yny1Iydt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BIO will be releasing a new Industry Analysis report Thursday on hypertension and heart failure. Request your copy now and receive it via email when it becomes available: https://bio.org/ia-reports pic.twitter.com/1frMqaLJmK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Download your copy of BIO’s first annual report on diversity and inclusion in biotechnology at http://RightMixMatters.org
#rightmixmatterspic.twitter.com/LfSI3RqiGl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BIO will be releasing a new Industry Analysis report Thursday on hypertension and heart failure. Request your copy now and receive it via email when it becomes available: https://bio.org/ia-reports pic.twitter.com/G5Rr33tZJU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Regional investors, including Mitsubishi UFJ Capital, MSQ Ventures, Shinsei Capital Partners Limited and Teijin Pharma Limited, will be looking for cross-border development at BIO Asia International Conference! See who you can partner with at
#BIOASIA20
http://bit.ly/2O7oqYm Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sign up for the BIO Boardlist to support our mission of promoting workforce development, diversity, and inclusion at http://RightMixMatters.org
#rightmixmatterspic.twitter.com/oAmwgkfsQL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Syneos Health provides capital solutions for biotechs by connecting innovators with the ‘right’ capital sources, and works with both to maximize ROI in a strategic ‘end to end’ model. Schedule a meeting with the Syneos team at
#BIOCEO20 to learn more.http://bit.ly/syneosheathHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
BIO is helping them fulfill that commitment by providing resources to help build a more inclusive and diverse workforce. Learn more at http://RightMixMatters.org
#rightmixmatterspic.twitter.com/6lTOYViSUV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Syneos One team at Syneos Health optimizes product development, thus creating the potential for cost efficiencies, increased speed to market, and de-risking of investment dollars. Meet us at
#BIOCEO20 and learn more.http://bit.ly/syneosheathHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.